← Back

Wire · opportunities

Will Labcorp's (LH) Digital Trial Upgrades and New Diagnostics Deal Subtly Shift Its Growth ...

Published

4 September 2026

Topic

opportunities

Sectors

Healthtech Infrastructure

Geography

United States

Source

Read at simplywall.st

Verified

Fusion42 · 4 September 2026 · Fusion42 review

Labcorp announced upgrades to its Global Trial Connect platform, launched new diagnostics tests including an FDA-cleared Alzheimer's blood test, and renewed a 10-year reference lab deal with the U.S. Defense Health Agency, strengthening its role in complex diagnostics and digital clinical trials.

This Wire brief sits within Fusion42's coverage of Healthtech Infrastructure.

◆ The Wire takeaway

Your clinical trial services just moved closer to biopharma long-term contracts with Labcorp’s upgraded platform and new diagnostics deals. Expect more opportunity to embed your tech into trials as Labcorp solidifies institutional partnerships.

Coverage

1 source · 4 Sep 2026

Related on Wire

Topics

Healthtech Infrastructureclinical-trialsdigital-healthdiagnosticsbiopharmaus-defense-health